The ALGOVUE Clinical Trial: Effects of the Daily Consumption of Eggs Enriched with Lutein and Docosahexaenoic Acid on Plasma Composition and Macular Pigment Optical Density.

Service Nutrition & Activité Physique, Institut Pasteur de Lille, F-59019 Lille, France. Centre des Sciences du Goût et de l'Alimentation, Agrosup Dijon, CNRS, INRA, Université Bourgogne Franche-Comté, F-21000 Dijon, France. ROQUETTE, F-62080 Lestrem, France. MIXSCIENCE, Centre d'Affaires Odyssée, ZAC Cicé Blossac, F-35172 Bruz, France. CNRS, INSERM, CHU de Lille, Institut Pasteur de Lille, UMR 1283-EGID, "Integrative Genomics and Modelling of Metabolic Diseases", Université de Lille, F-59045 Lille, France. "Bordeaux Population Health Research Center" (BPH), INSERM, UMR1219, "Lifelong Exposures, Health and Ageing" (LEHA) Group, Université de Bordeaux, F-33076 Bordeaux, France. CHU Lille, Service d'Exploration de la Vision et Neuro-Ophtalmologie, F-59000 Lille, France.

Nutrients. 2021;(10)
Full text from:

Other resources

Abstract

BACKGROUND Carotenoids and docosahexaenoic acid (DHA) were identified as essential components for eye health and are both naturally present in eggs. OBJECTIVE We aimed to evaluate the effect of the daily consumption of two eggs enriched with lutein/zeaxanthin and DHA on macular pigment optical density (MPOD) and on circulating xanthophyll and fatty acid concentrations in healthy participants. METHODS Ninety-nine healthy volunteers consumed either two standard eggs or two enriched eggs per day for 4 months. MPOD was measured at baseline (V0) and at follow-up (V4) using a modified confocal scanning laser ophthalmoscope (primary outcome). Blood samples were collected to determine total plasma and lipoprotein fatty acids and lutein/zeaxanthin compositions at V0 and V4 (secondary outcomes). RESULTS A slight but significant increase in MPOD was observed for all study participants consuming two eggs per day for 4 months at all eccentricities (0.5°, 1°, 2°, and 4°). Plasma and lipoprotein lutein, zeaxanthin, and DHA concentrations significantly increased in both groups but were greater in the enriched group (for the enriched group (V0 vs. V4): lutein, 167 vs. 369 ng/mL; zeaxanthin, 17.7 vs. 29.2 ng/mL; DHA, 1.89 vs. 2.56% of total fatty acids). Interestingly, lutein from high-density lipoprotein (HDL) was strongly correlated with MPOD at 0.5 and 1° eccentricities (rho = 0.385, p = 0.008, and rho = 0.461, p = 0.001, respectively). CONCLUSIONS MPOD was slightly increased in both groups. Lutein, zeaxanthin, and DHA plasma concentrations were strongly enhanced in the enriched group compared with the standard group. A significant correlation was found between MPOD level and lutein concentration in HDL.

Methodological quality

Publication Type : Clinical Trial

Metadata